Patents by Inventor Julia DEROGATIS

Julia DEROGATIS has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Conditional-siRNAS and uses thereof in treating cardiac hypertrophy
    Patent number: 12385041
    Abstract: Disclosed herein are conditional siRNAs activatable by pro-hypertrophic RNA sequences and use thereof for treating conditions such as cardiac hypertrophy. The conditional siRNAs target calcineurin or HDAC2.
    Type: Grant
    Filed: August 10, 2018
    Date of Patent: August 12, 2025
    Assignees: City of Hope, California Institute of Technology, The General Hospital Corporation
    Inventors: Saumya Das, Ane Miren Salvador Garicano, Si-ping Han, Lisa Scherer, Julia Derogatis, Robin Hu, Sahil Sagar, William A. Goddard, III, John Rossi
  • CONDITIONAL-siRNAS AND USES THEREOF IN TREATING CARDIAC HYPERTROPHY
    Publication number: 20230107117
    Abstract: Disclosed herein are conditional siRNAs activatable by pro-hypertrophic RNA sequences and use thereof for treating conditions such as cardiac hypertrophy. The conditional siRNAs target calcineurin or HDAC2.
    Type: Application
    Filed: August 10, 2018
    Publication date: April 6, 2023
    Applicants: CITY OF HOPE, CALIFORNIA INSTITUTE OF TECHNOLOGY, THE GENERAL HOSPITAL CORPORATION
    Inventors: Saumya DAS, Ane Miren SALVADOR GARICANO, Si-ping HAN, Lisa SCHERER, Julia DEROGATIS, Robin HU, Sahil SAGAR, William A. GODDARD, III, John ROSSI